Guest Editors: Michele Baccarani and Fabrizio Pane

A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA Michele Baccarani, Fabrizio Pane | DOI: 10.4084/mjhid.2014.010e2014010CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY Lodovico Balducci | DOI: 10.4084/mjhid.2014.037e2014037 Review ArticlesImatinib in Chronic Myeloid Leukemia: an Overview Tomasz Sacha | DOI: 10.4084/mjhid.2014.007e2014007MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML) Ibrahim C. Haznedaroglu | DOI: 10.4084/mjhid.2014.009e2014009TYROSINE KINASE INHIBITORS AND INTERFERON Maria Dimou, Panagiotis Panagiotidis | DOI: 10.4084/mjhid.2014.006e2014006SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs Massimo Breccia, Giuliana Alimena | DOI: 10.4084/mjhid.2014.003e2014003TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Gianantonio Rosti | DOI: 10.4084/mjhid.2014.005e2014005TYROSINE KINASE INHIBITORS AND PREGNANCY Elisabetta Abruzzese, Malgorzata Monika 
Trawinska, Paolo De Fabritiis, Alessio Pio Perrotti | DOI: 10.4084/mjhid.2014.028e2014028DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE Ibrahim C. Haznedaroglu | DOI: 10.4084/mjhid.2015.014